Cargando…
Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V
BACKGROUND: Scarce information is available regarding the long-term immunogenicity of the Sputnik V vaccine. Here Sputnik V vaccinated subjects were evaluated 6 months after receiving the 2-dose prime-boost schedule. METHODS: Eighty-six hospital workers from Venezuela, 32 with a previous COVID-19 in...
Autores principales: | Claro, Franklin, Silva, Douglas, Pérez Bogado, Jesús A., Rangel, Hector Rafael, de Waard, Jacobus H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176181/ https://www.ncbi.nlm.nih.gov/pubmed/35690364 http://dx.doi.org/10.1016/j.ijid.2022.06.008 |
Ejemplares similares
-
Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose
por: Claro, Franklin, et al.
Publicado: (2021) -
The arrival of Sputnik V
por: Balakrishnan, Vijay Shankar
Publicado: (2020) -
Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level
por: Godkov, Mikhail A., et al.
Publicado: (2022) -
Sputnik V vaccine goes global
por: Lawton, Graham
Publicado: (2021) -
Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)